866-997-4948(US-Canada Toll Free)

Global Urinary System Drugs Market Research Report 2017-2022 by Players, Regions, Product Types & Applications

Published By :

DataMarketResearch

Published Date : Aug 2017

Category :

Pharmaceutical

No. of Pages : 125 Pages

The global Urinary System Drugs market is valued at XX million USD in 2016 and is expected to reach XX million USD by the end of 2022, growing at a CAGR of XX% between 2016 and 2022.

This report offers an overview of the market trends, drivers, and barriers with respect to the Urinary System Drugs market. It also provides a detailed overview of the market of different regions across United States, Europe, China, Japan, India, Southeast Asia and Others. The report categorizes Urinary System Drugs market by by Loop diuretics, by Thiazide diuretic, by Thiazide-like diuretics, by potassium-sparing diuretics, by Vasopressin receptor antagonist, and application. Detailed analysis of key players, along with key growth strategies adopted by them is also covered in this report on Urinary System Drugs market is valued at XX million USD in 2016 and is expected to reach XX million USD by the end of 2022, growing at a CAGR of XX% between 2016 and 2022.

This report focuses Global market, it covers details as following:

Key Players
ALVOGEN MALTA
APOTEX INC
ARBOR PHARMS LLC
ASTRAZENECA
ATHENEX INC
BARR
CLARIS
DAIICHI SANKYO
DR REDDYS LABS LTD
EDENBRIDGE PHARMS
FRESENIUS KABI USA
GD SEARLE LLC
HOSPIRA
IPCA LABS LTD
IVAX SUB TEVA PHARMS
LUPIN LTD
MACLEODS PHARMS LTD
MERCK SHARP DOHME
MYLAN
PAR PHARM INC
PFIZER PHARMS
PRINSTON INC
SANDOZ
SANOFI AVENTIS US
SUN PHARM INDS INC
TEVA PHARMS
TORRENT PHARMS LTD
WATSON LABS
WEST-WARD PHARMS INT
WOCKHARDT

Key Regions
North America
United States
Canada
Latin America
Mexico
Brazil
Argentina
Others
Europe
Germany
United Kingdom
France
Italy
Spain
Russia
Netherland
Others
Asia & Pacific
China
Japan
India
Korea
Australia
Southeast Asia
Indonesia
Thailand
Philippines
Vietnam
Singapore
Malaysia
Others
Africa & Middle East
South Africa
Egypt
Turkey
Saudi Arabia
Iran
Others

Main types of products
Urinary System Drugs Market, by Loop diuretics
Furosemide
Bumetanide
Bumetanide
Ethacrynic Acid
Etozolin
Muzolimine
Piretanide
Ticrynafen
Torasemide
Urinary System Drugs Market, by Thiazide diuretic
Hydrochlorothiazide
Bendrofluazide
Hdyroflumethiazide
Polythiazide
Trichlormethiazide
Cyclopenthiazide
Methyclothiazide
Cyclothiazide
Mebutizide
Urinary System Drugs Market, by Thiazide-like diuretics
Quinethazone
Clopamide
Chlorthalidone
Mefruside
Clofenamide
Metolazone
Meticrane
Xipamide
Indapamide
Clorexolone
Fenquizone
Urinary System Drugs Market, by potassium-sparing diuretics
Amiloride
Triamterene
Spironolactone
Eplerenone
Canrenoate Potassium
Canrenone
Urinary System Drugs Market, by Vasopressin receptor antagoni
Conivaptan
Mozavaptan
Tolvaptan
Demeclocycline
Main Applications
Urology Surgery
department of nephropathy
Liver disease division
Hospital
Clinic

Table of Contents

Global Urinary System Drugs Market Research Report 2017-2022 by Players, Regions, Product Types & Applications
Chapter One Methodology and Data Source
1.1 Methodology/Research Approach
1.1.1 Research Programs/Design
1.1.2 Market Size Estimation
1.1.3 Market Breakdown and Data Triangulation
1.2 Data Source
1.2.1 Secondary Sources
1.2.2 Primary Sources
1.3 Disclaimer

Chapter Two Urinary System Drugs Market Overview
2.1 Market Coverage
2.2 Global Urinary System Drugs Market Sales Volume Revenue and Price 2012-2017

Chapter Three Urinary System Drugs by Key Players 2012-2017
3.1 Global Urinary System Drugs Sales Volume Market Share by Key Players 2012-2017
3.2 Global Urinary System Drugs Revenue Share by Key Players 2012-2017
3.3 Global Key Players Urinary System Drugs Key Product Model and Market Performance
3.4 Global Key Players Urinary System Drugs Key Target Consumers and Market Performance

Chapter Four Urinary System Drugs by Regions 2012-2017
4.1 Global Urinary System Drugs Sales Market Share by Regions 2012-2017
4.2 Global Urinary System Drugs Revenue Market Share by Regions 2012-2017
4.3 Global Urinary System Drugs Price by Regions 2012-2017
4.4 North America
4.4.1 United States
4.4.2 Canada
4.5 Latin America
4.5.1 Mexico
4.5.2 Brazil
4.5.3 Argentina
4.5.4 Others in Latin America
4.6 Europe
4.6.1 Germany
4.6.2 United Kingdom
4.6.3 France
4.6.4 Italy
4.6.5 Spain
4.6.6 Russia
4.6.7 Netherland
4.6.8 Others in Europe
4.7 Asia & Pacific
4.7.1 China
4.7.2 Japan
4.7.3 India
4.7.4 Korea
4.7.5 Australia
4.7.6 Southeast Asia
4.7.6.1 Indonesia
4.7.6.2 Thailand
4.7.6.3 Philippines
4.7.6.4 Vietnam
4.7.6.5 Singapore
4.7.6.6 Malaysia
4.7.6.7 Others in Southeast Asia
4.8 Africa & Middle East
4.8.1 South Africa
4.8.2 Egypt
4.8.3 Turkey
4.8.4 Saudi Arabia
4.8.5 Iran
4.8.6 Others in Africa & Middle East

Chapter Five Urinary System Drugs Market by Product Types
5.1 Urinary System Drugs, by Loop diuretics 2012-2017
5.1.1 Global Urinary System Drugs Sales Market Share by Loop diuretics 2012-2017
5.1.2 Global Urinary System Drugs Revenue Market Share by Loop diuretics 2012-2017
5.1.3 Global Urinary System Drugs Price by Loop diuretics 2012-2017
5.1.4 Furosemide
5.1.5 Bumetanide
5.1.6 Bumetanide
5.1.7 Ethacrynic Acid
5.1.8 Etozolin
5.2 Urinary System Drugs, by Thiazide diuretic 2012-2017
5.2.1 Global Urinary System Drugs Sales Market Share by Thiazide diuretic 2012-2017
5.2.2 Global Urinary System Drugs Revenue Market Share by Thiazide diuretic 2012-2017
5.2.3 Global Urinary System Drugs Price by Thiazide diuretic 2012-2017
5.2.4 Hydrochlorothiazide
5.2.5 Bendrofluazide
5.2.6 Hdyroflumethiazide
5.2.7 Polythiazide
5.2.8 Trichlormethiazide
5.3 Urinary System Drugs, by Thiazide-like diuretics 2012-2017
5.3.1 Global Urinary System Drugs Sales Market Share by Thiazide-like diuretics 2012-2017
5.3.2 Global Urinary System Drugs Revenue Market Share by Thiazide-like diuretics 2012-2017
5.3.3 Global Urinary System Drugs Price by Thiazide-like diuretics 2012-2017
5.3.4 Quinethazone
5.3.5 Clopamide
5.3.6 Chlorthalidone
5.3.7 Mefruside
5.3.8 Clofenamide
5.4 Urinary System Drugs, by potassium-sparing diuretics 2012-2017
5.4.1 Global Urinary System Drugs Sales Market Share by potassium-sparing diuretics 2012-2017
5.4.2 Global Urinary System Drugs Revenue Market Share by potassium-sparing diuretics 2012-2017
5.4.3 Global Urinary System Drugs Price by potassium-sparing diuretics 2012-2017
5.4.4 Amiloride
5.4.5 Triamterene
5.4.6 Spironolactone
5.4.7 Eplerenone
5.4.8 Canrenoate Potassium
5.5 Urinary System Drugs, by Vasopressin receptor antagonis 2012-2017
5.5.1 Global Urinary System Drugs Sales Market Share by Vasopressin receptor antagonis 2012-2017
5.5.2 Global Urinary System Drugs Revenue Market Share by Vasopressin receptor antagonis 2012-2017
5.5.3 Global Urinary System Drugs Price by Vasopressin receptor antagonis 2012-2017
5.5.4 Conivaptan
5.5.5 Mozavaptan
5.5.6 Tolvaptan
5.5.7 Demeclocycline

Chapter Six Global Key Players Profile
6.1 ALVOGEN MALTA
6.1.1 ALVOGEN MALTA Company Details and Competitors
6.1.2 ALVOGEN MALTA Key Urinary System Drugs Models and Performance
6.1.3 ALVOGEN MALTA Urinary System Drugs Business SWOT Analysis and Forecast
6.1.4 ALVOGEN MALTA Urinary System Drugs Sales Volume Revenue Price Cost and Gross Margin
6.2 APOTEX INC
6.2.1 APOTEX INC Company Details and Competitors
6.2.2 APOTEX INC Key Urinary System Drugs Models and Performance
6.2.3 APOTEX INC Urinary System Drugs Business SWOT Analysis and Forecast
6.2.4 APOTEX INC Urinary System Drugs Sales Volume Revenue Price Cost and Gross Margin
6.3 ARBOR PHARMS LLC
6.3.1 ARBOR PHARMS LLC Company Details and Competitors
6.3.2 ARBOR PHARMS LLC Key Urinary System Drugs Models and Performance
6.3.3 ARBOR PHARMS LLC Urinary System Drugs Business SWOT Analysis and Forecast
6.3.4 ARBOR PHARMS LLC Urinary System Drugs Sales Volume Revenue Price Cost and Gross Margin
6.4 ASTRAZENECA
6.4.1 ASTRAZENECA Company Details and Competitors
6.4.2 ASTRAZENECA Key Urinary System Drugs Models and Performance
6.4.3 ASTRAZENECA Urinary System Drugs Business SWOT Analysis and Forecast
6.4.4 ASTRAZENECA Urinary System Drugs Sales Volume Revenue Price Cost and Gross Margin
6.5 ATHENEX INC
6.5.1 ATHENEX INC Company Details and Competitors
6.5.2 ATHENEX INC Key Urinary System Drugs Models and Performance
6.5.3 ATHENEX INC Urinary System Drugs Business SWOT Analysis and Forecast
6.5.4 ATHENEX INC Urinary System Drugs Sales Volume Revenue Price Cost and Gross Margin
6.6 BARR
6.6.1 BARR Company Details and Competitors
6.6.2 BARR Key Urinary System Drugs Models and Performance
6.6.3 BARR Urinary System Drugs Business SWOT Analysis and Forecast
6.6.4 BARR Urinary System Drugs Sales Volume Revenue Price Cost and Gross Margin
6.7 CLARIS
6.7.1 CLARIS Company Details and Competitors
6.7.2 CLARIS Key Urinary System Drugs Models and Performance
6.7.3 CLARIS Urinary System Drugs Business SWOT Analysis and Forecast
6.7.4 CLARIS Urinary System Drugs Sales Volume Revenue Price Cost and Gross Margin
6.8 DAIICHI SANKYO
6.8.1 DAIICHI SANKYO Company Details and Competitors
6.8.2 DAIICHI SANKYO Key Urinary System Drugs Models and Performance
6.8.3 DAIICHI SANKYO Urinary System Drugs Business SWOT Analysis and Forecast
6.8.4 DAIICHI SANKYO Urinary System Drugs Sales Volume Revenue Price Cost and Gross Margin
6.9 DR REDDYS LABS LTD
6.9.1 DR REDDYS LABS LTD Company Details and Competitors
6.9.2 DR REDDYS LABS LTD Key Urinary System Drugs Models and Performance
6.9.3 DR REDDYS LABS LTD Urinary System Drugs Business SWOT Analysis and Forecast
6.9.4 DR REDDYS LABS LTD Urinary System Drugs Sales Volume Revenue Price Cost and Gross Margin
6.10 EDENBRIDGE PHARMS
6.10.1 EDENBRIDGE PHARMS Company Details and Competitors
6.10.2 EDENBRIDGE PHARMS Key Urinary System Drugs Models and Performance
6.10.3 EDENBRIDGE PHARMS Urinary System Drugs Business SWOT Analysis and Forecast
6.10.4 EDENBRIDGE PHARMS Urinary System Drugs Sales Volume Revenue Price Cost and Gross Margin
6.11 FRESENIUS KABI USA
6.12 GD SEARLE LLC
6.13 HOSPIRA
6.14 IPCA LABS LTD
6.15 IVAX SUB TEVA PHARMS
6.16 LUPIN LTD
6.17 MACLEODS PHARMS LTD
6.18 MERCK SHARP DOHME
6.19 MYLAN
6.20 PAR PHARM INC
6.21 PFIZER PHARMS
6.22 PRINSTON INC
6.23 SANDOZ
6.24 SANOFI AVENTIS US
6.25 SUN PHARM INDS INC
6.26 TEVA PHARMS
6.27 TORRENT PHARMS LTD
6.28 WATSON LABS
6.29 WEST-WARD PHARMS INT
6.30 WOCKHARDT

Chapter Seven Urinary System Drugs by Appliance 2012-2017
7.1 Global Urinary System Drugs Sales Market Share by Appliance 2012-2017
7.2 Urology Surgery
7.3 department of nephropathy
7.4 Liver disease division
7.5 Hospital
7.6 Clinic
7.7 Consuming Habit and Preference

Chapter Eight Industry Chain and Supply Chain
8.1 Urinary System Drugs Industry Chain Structure
8.1.1 R&D
8.1.2 Raw Materials (Components)
8.1.3 Manufacturing Plants
8.1.4 Regional Trading (Import Export and Local Sales)
8.1.5 Online Sales Channel
8.1.6 Offline Channel
8.1.7 End Users
8.2 Urinary System Drugs Manufacturing
8.2.1 Key Components
8.2.2 Assembly Manufacturing
8.3 Consumer Preference
8.4 Behavioral Habits
8.5 Marketing Environment

Chapter Nine Global Urinary System Drugs Market Size (Sales and Revenue) Forecast (2017-2022)
9.1 Global Urinary System Drugs Sales (), Revenue (Million USD) Forecast (2017-2022)
9.2 Global Urinary System Drugs Sales () Forecast by Regions (2017-2022)
9.3 Global Urinary System Drugs Sales () Forecast by Application (2017-2022)
9.4 Global Urinary System Drugs Sales () Forecast by Loop diuretics (2017-2022)
9.5 Global Urinary System Drugs Sales () Forecast by Thiazide diuretic (2017-2022)
9.6 Global Urinary System Drugs Sales () Forecast by Thiazide-like diuretics (2017-2022)
9.7 Global Urinary System Drugs Sales () Forecast by potassium-sparing diuretics (2017-2022)
9.8 Global Urinary System Drugs Sales () Forecast by Vasopressin receptor antagonis (2017-2022)

Chapter Ten Development Trend and Research Conclusion
10.1 Development Trend
10.2 Research Conclusion


List of Table

List of Tables and Figures

Table Global Urinary System Drugs Sales Volume (), Revenue (Million USD) and Price ()(2012-2017)
Figure Global Urinary System Drugs Revenue (Million USD) and Growth Rate (2012-2017)
Figure Global Urinary System Drugs Sales Volume () and Growth Rate (2012-2017)
Table Global Urinary System Drugs Sales Volume () by Key Players (2012-2017)
Table Global Urinary System Drugs Sales Volume Market Share by Key Players (2012-2017)
Figure Global Urinary System Drugs Sales Volume Market Share by Key Players 2016
Figure Global Urinary System Drugs Sales Volume Market Share by Key Players 2017
Table Global Urinary System Drugs Revenue (Million USD) by Key Players (2012-2017)
Table Global Urinary System Drugs Revenue Market Share by Key Players (2012-2017)
Figure Global Urinary System Drugs Revenue Market Share by Key Players 2016
Figure Global Urinary System Drugs Revenue Market Share by Key Players 2017
Table Global Key Players Key Product Model and Market Performance
Table Global Key Players Key Target Consumers and Market Performance
Table Global Urinary System Drugs Sales () by Regions (2012-2017)
Table Global Urinary System Drugs Sales Share by Regions (2012-2017)
Figure Global Urinary System Drugs Sales Market Share by Regions in 2016
Figure Global Urinary System Drugs Sales Market Share by Regions in 2017
Table Global Urinary System Drugs Revenue (Million USD) by Regions (2012-2017)
Table Global Urinary System Drugs Revenue Market Share by Regions (2012-2017)
Figure Global Urinary System Drugs Revenue Market Share by Regions in 2016
Figure Global Urinary System Drugs Revenue Market Share by Regions in 2017
Table Global Urinary System Drugs Price () by Regions (2012-2017)
Table North America Urinary System Drugs Sales () by Regions (2012-2017)
Table North America Urinary System Drugs Revenue (Million USD) by Regions (2012-2017)
Table North America Urinary System Drugs Sales Volume () by Key Players 2012-2017
Figure North America Urinary System Drugs Sales () and Growth Rate (2012-2017)
Table Latin America Urinary System Drugs Sales () by Regions (2012-2017)
Table Latin America Urinary System Drugs Revenue (Million USD) by Regions (2012-2017)
Table Latin America Urinary System Drugs Sales Volume () by Key Players (2012-2017)
Figure Latin America Urinary System Drugs Sales () and Growth Rate (2012-2017)
Table Europe Urinary System Drugs Sales () by Regions (2012-2017)
Table Europe Urinary System Drugs Revenue (Million USD) by Regions (2012-2017)
Table Europe Urinary System Drugs Sales Volume () by Key Players (2012-2017)
Figure Europe Urinary System Drugs Sales () and Growth Rate (2012-2017)
Table Asia & Pacific Urinary System Drugs Sales () by Regions (2012-2017)
Table Asia & Pacific Urinary System Drugs Revenue (Million USD) by Regions (2012-2017)
Table Asia & Pacific Urinary System Drugs Sales Volume () by Key Players (2012-2017)
Figure Asia & Pacific Urinary System Drugs Sales () and Growth Rate (2012-2017)
Table Africa & Middle East Urinary System Drugs Sales () by Regions (2012-2017)
Table Africa & Middle East Urinary System Drugs Revenue (Million USD) by Regions (2012-2017)
Table Africa & Middle East Urinary System Drugs Sales Volume () by Key Players (2012-2017)
Figure Africa & Middle East Urinary System Drugs Sales () and Growth Rate (2012-2017)
Table Global Urinary System Drugs Sales () by Loop diuretics (2012-2017)
Table Global Urinary System Drugs Sales Market Share by Loop diuretics (2012-2017)
Figure Global Urinary System Drugs Sales Market Share by Loop diuretics in 2016
Table Global Urinary System Drugs Revenue (Million USD) by Loop diuretics (2012-2017)
Table Global Urinary System Drugs Revenue Market Share by Loop diuretics (2012-2017)
Figure Global Urinary System Drugs Revenue Market Share by Loop diuretics in 2016
Table Global Urinary System Drugs Price () by Loop diuretics (2012-2017)
Table Top Players of Furosemide Urinary System Drugs Products List
Figure Global Furosemide Urinary System Drugs Sales () and Growth Rate (2012-2017)
Table Top Players of Bumetanide Urinary System Drugs Products List
Figure Global Bumetanide Urinary System Drugs Sales () and Growth Rate (2012-2017)
Table Top Players of Bumetanide Urinary System Drugs Products List
Figure Global Bumetanide Urinary System Drugs Sales () and Growth Rate (2012-2017)
Table Top Players of Ethacrynic Acid Urinary System Drugs Products List
Figure Global Ethacrynic Acid Urinary System Drugs Sales () and Growth Rate (2012-2017)
Table Top Players of Etozolin Urinary System Drugs Products List
Figure Global Etozolin Urinary System Drugs Sales () and Growth Rate (2012-2017)
Table Global Urinary System Drugs Sales () by Thiazide diuretic (2012-2017)
Table Global Urinary System Drugs Sales Market Share by Thiazide diuretic (2012-2017)
Figure Global Urinary System Drugs Sales Market Share by Thiazide diuretic in 2016
Table Global Urinary System Drugs Revenue (Million USD) by Thiazide diuretic (2012-2017)
Table Global Urinary System Drugs Revenue Market Share by Thiazide diuretic (2012-2017)
Figure Global Urinary System Drugs Revenue Market Share by Thiazide diuretic in 2016
Table Global Urinary System Drugs Price () by Thiazide diuretic (2012-2017)
Table Top Players of Hydrochlorothiazide Urinary System Drugs Products List
Figure Global Hydrochlorothiazide Urinary System Drugs Sales () and Growth Rate (2012-2017)
Table Top Players of Bendrofluazide Urinary System Drugs Products List
Figure Global Bendrofluazide Urinary System Drugs Sales () and Growth Rate (2012-2017)
Table Top Players of Hdyroflumethiazide Urinary System Drugs Products List
Figure Global Hdyroflumethiazide Urinary System Drugs Sales () and Growth Rate (2012-2017)
Table Top Players of Polythiazide Urinary System Drugs Products List
Figure Global Polythiazide Urinary System Drugs Sales () and Growth Rate (2012-2017)
Table Top Players of Trichlormethiazide Urinary System Drugs Products List
Figure Global Trichlormethiazide Urinary System Drugs Sales () and Growth Rate (2012-2017)
Table Global Urinary System Drugs Sales () by Thiazide-like diuretics (2012-2017)
Table Global Urinary System Drugs Sales Market Share by Thiazide-like diuretics (2012-2017)
Figure Global Urinary System Drugs Sales Market Share by Thiazide-like diuretics in 2016
Table Global Urinary System Drugs Revenue (Million USD) by Thiazide-like diuretics (2012-2017)
Table Global Urinary System Drugs Revenue Market Share by Thiazide-like diuretics (2012-2017)
Figure Global Urinary System Drugs Revenue Market Share by Thiazide-like diuretics in 2016
Table Global Urinary System Drugs Price () by Thiazide-like diuretics (2012-2017)
Table Top Players of Quinethazone Urinary System Drugs Products List
Figure Global Quinethazone Urinary System Drugs Sales () and Growth Rate (2012-2017)
Table Top Players of Clopamide Urinary System Drugs Products List
Figure Global Clopamide Urinary System Drugs Sales () and Growth Rate (2012-2017)
Table Top Players of Chlorthalidone Urinary System Drugs Products List
Figure Global Chlorthalidone Urinary System Drugs Sales () and Growth Rate (2012-2017)
Table Top Players of Mefruside Urinary System Drugs Products List
Figure Global Mefruside Urinary System Drugs Sales () and Growth Rate (2012-2017)
Table Top Players of Clofenamide Urinary System Drugs Products List
Figure Global Clofenamide Urinary System Drugs Sales () and Growth Rate (2012-2017)
Table Global Urinary System Drugs Sales () by potassium-sparing diuretics (2012-2017)
Table Global Urinary System Drugs Sales Market Share by potassium-sparing diuretics (2012-2017)
Figure Global Urinary System Drugs Sales Market Share by potassium-sparing diuretics in 2016
Table Global Urinary System Drugs Revenue (Million USD) by potassium-sparing diuretics (2012-2017)
Table Global Urinary System Drugs Revenue Market Share by potassium-sparing diuretics (2012-2017)
Figure Global Urinary System Drugs Revenue Market Share by potassium-sparing diuretics in 2016
Table Global Urinary System Drugs Price () by potassium-sparing diuretics (2012-2017)
Table Top Players of Amiloride Urinary System Drugs Products List
Figure Global Amiloride Urinary System Drugs Sales () and Growth Rate (2012-2017)
Table Top Players of Triamterene Urinary System Drugs Products List
Figure Global Triamterene Urinary System Drugs Sales () and Growth Rate (2012-2017)
Table Top Players of Spironolactone Urinary System Drugs Products List
Figure Global Spironolactone Urinary System Drugs Sales () and Growth Rate (2012-2017)
Table Top Players of Eplerenone Urinary System Drugs Products List
Figure Global Eplerenone Urinary System Drugs Sales () and Growth Rate (2012-2017)
Table Top Players of Canrenoate Potassium Urinary System Drugs Products List
Figure Global Canrenoate Potassium Urinary System Drugs Sales () and Growth Rate (2012-2017)
Table Global Urinary System Drugs Sales () by Vasopressin receptor antagonis (2012-2017)
Table Global Urinary System Drugs Sales Market Share by Vasopressin receptor antagonis (2012-2017)
Figure Global Urinary System Drugs Sales Market Share by Vasopressin receptor antagonis in 2016
Table Global Urinary System Drugs Revenue (Million USD) by Vasopressin receptor antagonis (2012-2017)
Table Global Urinary System Drugs Revenue Market Share by Vasopressin receptor antagonis (2012-2017)
Figure Global Urinary System Drugs Revenue Market Share by Vasopressin receptor antagonis in 2016
Table Global Urinary System Drugs Price () by Vasopressin receptor antagonis (2012-2017)
Table Top Players of Conivaptan Urinary System Drugs Products List
Figure Global Conivaptan Urinary System Drugs Sales () and Growth Rate (2012-2017)
Table Top Players of Mozavaptan Urinary System Drugs Products List
Figure Global Mozavaptan Urinary System Drugs Sales () and Growth Rate (2012-2017)
Table Top Players of Tolvaptan Urinary System Drugs Products List
Figure Global Tolvaptan Urinary System Drugs Sales () and Growth Rate (2012-2017)
Table Top Players of Demeclocycline Urinary System Drugs Products List
Figure Global Demeclocycline Urinary System Drugs Sales () and Growth Rate (2012-2017)
Table ALVOGEN MALTA Company Details and Competitors
Table ALVOGEN MALTA Key Urinary System Drugs Models and Performance
Table ALVOGEN MALTA Urinary System Drugs Business SWOT Analysis and Forecast
Table ALVOGEN MALTA Urinary System Drugs Output (), Revenue (Million USD), Price () and Gross Margin (%)(2012-2017)
Figure ALVOGEN MALTA Urinary System Drugs Sales(Million Unit) and Growth Rate (%)(2012-2017)
Figure ALVOGEN MALTA Urinary System Drugs Sales Market Share (%) in Global (2012-2017)
Figure ALVOGEN MALTA Urinary System Drugs Sales Revenue(Million USD) and Growth Rate (%)(2012-2017)
Figure ALVOGEN MALTA Urinary System Drugs Revenue Market Share (%) in Global (2012-2017)
Table APOTEX INC Company Details and Competitors
Table APOTEX INC Key Urinary System Drugs Models and Performance
Table APOTEX INC Urinary System Drugs Business SWOT Analysis and Forecast
Table APOTEX INC Urinary System Drugs Output (), Revenue (Million USD), Price () and Gross Margin (%)(2012-2017)
Figure APOTEX INC Urinary System Drugs Sales(Million Unit) and Growth Rate (%)(2012-2017)
Figure APOTEX INC Urinary System Drugs Sales Market Share (%) in Global (2012-2017)
Figure APOTEX INC Urinary System Drugs Sales Revenue(Million USD) and Growth Rate (%)(2012-2017)
Figure APOTEX INC Urinary System Drugs Revenue Market Share (%) in Global (2012-2017)
Table ARBOR PHARMS LLC Company Details and Competitors
Table ARBOR PHARMS LLC Key Urinary System Drugs Models and Performance
Table ARBOR PHARMS LLC Urinary System Drugs Business SWOT Analysis and Forecast
Table ARBOR PHARMS LLC Urinary System Drugs Output (), Revenue (Million USD), Price () and Gross Margin (%)(2012-2017)
Figure ARBOR PHARMS LLC Urinary System Drugs Sales(Million Unit) and Growth Rate (%)(2012-2017)
Figure ARBOR PHARMS LLC Urinary System Drugs Sales Market Share (%) in Global (2012-2017)
Figure ARBOR PHARMS LLC Urinary System Drugs Sales Revenue(Million USD) and Growth Rate (%)(2012-2017)
Figure ARBOR PHARMS LLC Urinary System Drugs Revenue Market Share (%) in Global (2012-2017)
Table ASTRAZENECA Company Details and Competitors
Table ASTRAZENECA Key Urinary System Drugs Models and Performance
Table ASTRAZENECA Urinary System Drugs Business SWOT Analysis and Forecast
Table ASTRAZENECA Urinary System Drugs Output (), Revenue (Million USD), Price () and Gross Margin (%)(2012-2017)
Figure ASTRAZENECA Urinary System Drugs Sales(Million Unit) and Growth Rate (%)(2012-2017)
Figure ASTRAZENECA Urinary System Drugs Sales Market Share (%) in Global (2012-2017)
Figure ASTRAZENECA Urinary System Drugs Sales Revenue(Million USD) and Growth Rate (%)(2012-2017)
Figure ASTRAZENECA Urinary System Drugs Revenue Market Share (%) in Global (2012-2017)
Table ATHENEX INC Company Details and Competitors
Table ATHENEX INC Key Urinary System Drugs Models and Performance
Table ATHENEX INC Urinary System Drugs Business SWOT Analysis and Forecast
Table ATHENEX INC Urinary System Drugs Output (), Revenue (Million USD), Price () and Gross Margin (%)(2012-2017)
Figure ATHENEX INC Urinary System Drugs Sales(Million Unit) and Growth Rate (%)(2012-2017)
Figure ATHENEX INC Urinary System Drugs Sales Market Share (%) in Global (2012-2017)
Figure ATHENEX INC Urinary System Drugs Sales Revenue(Million USD) and Growth Rate (%)(2012-2017)
Figure ATHENEX INC Urinary System Drugs Revenue Market Share (%) in Global (2012-2017)
Table BARR Company Details and Competitors
Table BARR Key Urinary System Drugs Models and Performance
Table BARR Urinary System Drugs Business SWOT Analysis and Forecast
Table BARR Urinary System Drugs Output (), Revenue (Million USD), Price () and Gross Margin (%)(2012-2017)
Figure BARR Urinary System Drugs Sales(Million Unit) and Growth Rate (%)(2012-2017)
Figure BARR Urinary System Drugs Sales Market Share (%) in Global (2012-2017)
Figure BARR Urinary System Drugs Sales Revenue(Million USD) and Growth Rate (%)(2012-2017)
Figure BARR Urinary System Drugs Revenue Market Share (%) in Global (2012-2017)
Table CLARIS Company Details and Competitors
Table CLARIS Key Urinary System Drugs Models and Performance
Table CLARIS Urinary System Drugs Business SWOT Analysis and Forecast
Table CLARIS Urinary System Drugs Output (), Revenue (Million USD), Price () and Gross Margin (%)(2012-2017)
Figure CLARIS Urinary System Drugs Sales(Million Unit) and Growth Rate (%)(2012-2017)
Figure CLARIS Urinary System Drugs Sales Market Share (%) in Global (2012-2017)
Figure CLARIS Urinary System Drugs Sales Revenue(Million USD) and Growth Rate (%)(2012-2017)
Figure CLARIS Urinary System Drugs Revenue Market Share (%) in Global (2012-2017)
Table DAIICHI SANKYO Company Details and Competitors
Table DAIICHI SANKYO Key Urinary System Drugs Models and Performance
Table DAIICHI SANKYO Urinary System Drugs Business SWOT Analysis and Forecast
Table DAIICHI SANKYO Urinary System Drugs Output (), Revenue (Million USD), Price () and Gross Margin (%)(2012-2017)
Figure DAIICHI SANKYO Urinary System Drugs Sales(Million Unit) and Growth Rate (%)(2012-2017)
Figure DAIICHI SANKYO Urinary System Drugs Sales Market Share (%) in Global (2012-2017)
Figure DAIICHI SANKYO Urinary System Drugs Sales Revenue(Million USD) and Growth Rate (%)(2012-2017)
Figure DAIICHI SANKYO Urinary System Drugs Revenue Market Share (%) in Global (2012-2017)
Table DR REDDYS LABS LTD Company Details and Competitors
Table DR REDDYS LABS LTD Key Urinary System Drugs Models and Performance
Table DR REDDYS LABS LTD Urinary System Drugs Business SWOT Analysis and Forecast
Table DR REDDYS LABS LTD Urinary System Drugs Output (), Revenue (Million USD), Price () and Gross Margin (%)(2012-2017)
Figure DR REDDYS LABS LTD Urinary System Drugs Sales(Million Unit) and Growth Rate (%)(2012-2017)
Figure DR REDDYS LABS LTD Urinary System Drugs Sales Market Share (%) in Global (2012-2017)
Figure DR REDDYS LABS LTD Urinary System Drugs Sales Revenue(Million USD) and Growth Rate (%)(2012-2017)
Figure DR REDDYS LABS LTD Urinary System Drugs Revenue Market Share (%) in Global (2012-2017)
Table EDENBRIDGE PHARMS Company Details and Competitors
Table EDENBRIDGE PHARMS Key Urinary System Drugs Models and Performance
Table EDENBRIDGE PHARMS Urinary System Drugs Business SWOT Analysis and Forecast
Table EDENBRIDGE PHARMS Urinary System Drugs Output (), Revenue (Million USD), Price () and Gross Margin (%)(2012-2017)
Figure EDENBRIDGE PHARMS Urinary System Drugs Sales(Million Unit) and Growth Rate (%)(2012-2017)
Figure EDENBRIDGE PHARMS Urinary System Drugs Sales Market Share (%) in Global (2012-2017)
Figure EDENBRIDGE PHARMS Urinary System Drugs Sales Revenue(Million USD) and Growth Rate (%)(2012-2017)
Figure EDENBRIDGE PHARMS Urinary System Drugs Revenue Market Share (%) in Global (2012-2017)
Table FRESENIUS KABI USA Company Details and Competitors
Table GD SEARLE LLC Company Details and Competitors
Table HOSPIRA Company Details and Competitors
Table IPCA LABS LTD Company Details and Competitors
Table IVAX SUB TEVA PHARMS Company Details and Competitors
Table LUPIN LTD Company Details and Competitors
Table MACLEODS PHARMS LTD Company Details and Competitors
Table MERCK SHARP DOHME Company Details and Competitors
Table MYLAN Company Details and Competitors
Table PAR PHARM INC Company Details and Competitors
Table PFIZER PHARMS Company Details and Competitors
Table PRINSTON INC Company Details and Competitors
Table SANDOZ Company Details and Competitors
Table SANOFI AVENTIS US Company Details and Competitors
Table SUN PHARM INDS INC Company Details and Competitors
Table TEVA PHARMS Company Details and Competitors
Table TORRENT PHARMS LTD Company Details and Competitors
Table WATSON LABS Company Details and Competitors
Table WEST-WARD PHARMS INT Company Details and Competitors
Table WOCKHARDT Company Details and Competitors
Table Global Urinary System Drugs Sales () by Appliance (2012-2017)
Figure Global Urinary System Drugs Sales Market Share by Appliance (2012-2017)
Figure Global Urinary System Drugs Sales Market Share by Appliance in 2016
Figure Global Urology Surgery Urinary System Drugs Sales () and Growth Rate (2012-2017)
Figure Global department of nephropathy Urinary System Drugs Sales () and Growth Rate (2012-2017)
Figure Global Liver disease division Urinary System Drugs Sales () and Growth Rate (2012-2017)
Figure Global Hospital Urinary System Drugs Sales () and Growth Rate (2012-2017)
Figure Global Clinic Urinary System Drugs Sales () and Growth Rate (2012-2017)
Figure Global Urinary System Drugs Sales () and Growth Rate (%) Forecast (2017-2022)
Figure Global Urinary System Drugs Revenue (Million USD) and Growth Rate Forecast (2017-2022)
Figure Global Urinary System Drugs Price () Trend Forecast (2017-2022)
Table Global Urinary System Drugs Sales () Forecast by Regions (2017-2022)
Table Global Urinary System Drugs Sales Volume Share Forecast by Regions (2017-2022)
Figure Global Urinary System Drugs Sales Volume Share Forecast by Regions (2017-2022)
Figure Global Urinary System Drugs Sales Volume Share Forecast by Regions in 2022
Table Global Urinary System Drugs Sales () Forecast by Application (2017-2022)
Figure Global Urinary System Drugs Sales Volume Market Share Forecast by Application (2017-2022)
Figure Global Urinary System Drugs Sales Volume Market Share Forecast by Application in 2022
Table Global Urinary System Drugs Sales () Forecast by Loop diuretics (2017-2022)
Figure Global Urinary System Drugs Sales () Forecast by Loop diuretics (2017-2022)
Figure Global Urinary System Drugs Sales Volume Market Share Forecast by Loop diuretics in 2022
Table Global Urinary System Drugs Sales () Forecast by Thiazide diuretic (2017-2022)
Figure Global Urinary System Drugs Sales () Forecast by Thiazide diuretic (2017-2022)
Figure Global Urinary System Drugs Sales Volume Market Share Forecast by Thiazide diuretic in 2022
Table Global Urinary System Drugs Sales () Forecast by Thiazide-like diuretics (2017-2022)
Figure Global Urinary System Drugs Sales () Forecast by Thiazide-like diuretics (2017-2022)
Figure Global Urinary System Drugs Sales Volume Market Share Forecast by Thiazide-like diuretics in 2022
Table Global Urinary System Drugs Sales () Forecast by potassium-sparing diuretics (2017-2022)
Figure Global Urinary System Drugs Sales () Forecast by potassium-sparing diuretics (2017-2022)
Figure Global Urinary System Drugs Sales Volume Market Share Forecast by potassium-sparing diuretics in 2022
Table Global Urinary System Drugs Sales () Forecast by Vasopressin receptor antagonis (2017-2022)
Figure Global Urinary System Drugs Sales () Forecast by Vasopressin receptor antagonis (2017-2022)
Figure Global Urinary System Drugs Sales Volume Market Share Forecast by Vasopressin receptor antagonis in 2022

Make an enquiry before buying this Report

Please fill the enquiry form below.

  • Full Name *
  • Your Email *
  • Job Title *
  • Company *
  • Phone No. * (Pls. Affix Country Code)
  • Message
  • Security Code *